UK-based retailer Sainsbury's has called for the introduction of a single method of displaying nutritional details on printed labels for food products to help public make informed decisions. Over the years, many systems have been used to ...
Tags: retailer, labels for food, systems, UK government
HTG Molecular Diagnostics has partnered John Wayne Cancer Institute (JWCI) to sell its HTG melanoma signature assays. The signature assays are intended to be useful for diagnostic and prognostic applications along the melanoma continuum. ...
Tags: HTG Molecular, JWCI, melanoma signature, signature assays
Guided Therapeutics has extended third consecutive year licensing agreement with Konica Minolta Technology Center to co-develop a non-invasive Barrett's Esophagus detection product. The Barrett's Esophagus product is based on the Guided ...
Tags: Guided, licensing agreement, Konica, co-develop
NeoGenomics has introduced NeoTYPE prognostic panel for detection of mutations in splicing factor 3b subunit 1 (SF3B1) gene of chronic lymphocytic leukemia (CLL) in the US. The CLL Profile panel also includes assays for IgVH mutation ...
Tags: NeoGenomics, prognostic panel, CLL Profile panel, FISH tests
Health insurer Life Insurance of North America (LINA) will pay over $1.7m to consumers and the Commonwealth, The Massachusetts Attorney General Martha Coakley has announced. The insurer was accused to sell its cancer and surgical ...
Tags: LINA, marketing of insurance, Commonwealth
Lab21 has entered into a collaboration agreement to develop polymerase chain reaction-based assays on BD Diagnostics' automated BD MAX molecular system for a series of oncology markers. The two assays, which will be initially developed, ...
Tags: Lab21, collaboration agreement, BD Diagnostics, reaction-based assays
The United States Patent and Trademark Office has issued a patent for Lorus Therapeutics' LOR-253, which covers composition of matter and methods of treating cancer. The patent was initially set to expire in May 2026 and latter was ...
Australian High Court has dismissed claims by tobacco companies that the government illegally seized their intellectual property by barring the display of trademarks on packs and gave its approval to go ahead with a ban on color cigarette ...
Tags: Tobacco Pack Logo, color cigarette packaging, cigarette packaging
Pathwork Diagnostics, a developer of oncology diagnostics assays, has named Lee McCracken as the company's new chief executive officer (CEO). Pathwork Diagnostics board chairman Peter Klemm said,"Lee, with his considerable leadership and ...
Tags: Pathwork Diagnostics, Lee McCracken, CEO
Roche Group member, Genentech has received US Food and Drug Administration (FDA) official approval of priority review designation for trastuzumab emtansine Biologics License Application (BLA). Trastuzumab Emtansine is designed to treat ...
Ventana Medical Systems, a member of the Roche Group, has launched a new fully-automated staining technique that allows researchers to visualize miRNAs and proteins related to cancer in the same section of tumor tissue. Detection of ...
Tags: Ventana, staining technique, cancer detection, miRNAs
Multinational biopharmaceutical company Celgene has received US Food and Drug Administration (FDA) approval for Abraxane, which is aimed to treat locally advanced or metastatic non-small cell lung cancer in combination with carboplatin in ...
Tags: Abraxane, lung cancer, Multinational biopharmaceutical company Celgene
The US Patent and Trademark Office (USPTO) has granted a US Patent NO 8,185,485 B2 to Lifeline Biotechnologies' device used for analyzing thermal data based on breast surface temperature for the detection for use in determining cancerous ...
Tags: USPTO, Lifeline Biotechnologies'device, analyzing, surface temperature
Threshold Pharmaceutical has received orphan drug designation for TH-302, a cancer drug, from the US FDA. Threshold is presently testing TH-302 along with a commonly used chemotherapeutic agent, doxorubicin, in a late-stage trial to treat ...
The Institute of Cancer Research (ICR) has selected Labcyte's Access workstation to automate the production of low-volume, assay-ready microplates from high-throughput screening and fragment libraries for biochemical, cell-based, and ...
Tags: ICR, Access workstation, automate, microplates